These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11927115)

  • 1. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years.
    Hidalgo M; Bahamondes L; Perrotti M; Diaz J; Dantas-Monteiro C; Petta C
    Contraception; 2002 Feb; 65(2):129-32. PubMed ID: 11927115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of menorrhagia with a novel 'frameless' intrauterine levonorgestrel-releasing drug delivery system: a pilot study.
    Wildemeersch D; Schacht E
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):93-101. PubMed ID: 11518454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Femilis LNG-IUS: contraceptive performance-an interim analysis.
    Wildemeersch D; Janssens D; Andrade A
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):103-10. PubMed ID: 19340705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a 5-year contraceptive trial in parous and nulliparous women with a new LNG-IUS.
    Wildemeersch D; Goldstuck ND; Jackers G
    Gynecol Endocrinol; 2017 Mar; 33(3):223-226. PubMed ID: 28084114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding pattern and user satisfaction in second consecutive levonorgestrel-releasing intrauterine system users: results of a prospective 5-year study.
    Heikinheimo O; Inki P; Schmelter T; Gemzell-Danielsson K
    Hum Reprod; 2014 Jun; 29(6):1182-8. PubMed ID: 24682613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of baseline bleeding pattern on amenorrhea with levonorgestrel intrauterine system use.
    Mejia M; McNicholas C; Madden T; Peipert JF
    Contraception; 2016 Nov; 94(5):556-560. PubMed ID: 27364099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic use of levonorgestrel-releasing intrauterine system in women with menorrhagia: a pilot study(1).
    Monteiro I; Bahamondes L; Diaz J; Perrotti M; Petta C
    Contraception; 2002 May; 65(5):325-8. PubMed ID: 12057782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial.
    Jensen JT; Lukkari-Lax E; Schulze A; Wahdan Y; Serrani M; Kroll R
    Am J Obstet Gynecol; 2022 Dec; 227(6):873.e1-873.e12. PubMed ID: 36096186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of oligoamenorrhea at 1-year follow-up in premenopausal women using a levonorgestrel-releasing intrauterine system.
    de Jonge ET; Yigit R; Molenberghs G; Straetmans D; Ombelet W
    Contraception; 2007 Aug; 76(2):91-5. PubMed ID: 17656176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties.
    Luukkainen T; Toivonen J
    Contraception; 1995 Nov; 52(5):269-76. PubMed ID: 8585882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
    Sivin I; el Mahgoub S; McCarthy T; Mishell DR; Shoupe D; Alvarez F; Brache V; Jimenez E; Diaz J; Faundes A
    Contraception; 1990 Oct; 42(4):361-78. PubMed ID: 2124179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
    Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
    Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain and bleeding pattern related to levonorgestrel intrauterine system (LNG-IUS) insertion.
    Van Schoubroeck D; Van den Bosch T; Ameye L; Veldman J; Hindryckx A; Werbrouck E; Timmerman D
    Eur J Obstet Gynecol Reprod Biol; 2013 Nov; 171(1):154-6. PubMed ID: 24029596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amenorrhea rates and predictors during 1 year of levonorgestrel 52 mg intrauterine system use.
    Darney PD; Stuart GS; Thomas MA; Cwiak C; Olariu A; Creinin MD
    Contraception; 2018 Mar; 97(3):210-214. PubMed ID: 29038072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability and performance of the levonorgestrel-releasing intrauterine system (Mirena) in Campinas, Brazil.
    Diaz J; Bahamondes L; Monteiro I; Petta C; Hildalgo MM; Arce XE
    Contraception; 2000 Aug; 62(2):59-61. PubMed ID: 11102588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
    Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two Years Follow-Up of Patients with Abnormal Uterine Bleeding after Insertion of the Levonorgestrel-Releasing Intrauterine System.
    Cim N; Soysal S; Sayan S; Yildizhan B; Karaman E; Cetin O; Tolunay HE; Yildizhan R
    Gynecol Obstet Invest; 2018; 83(6):569-575. PubMed ID: 29223999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, acceptability and side effects of the levonorgestrel intrauterine system for menorrhagia.
    Kriplani A; Singh BM; Lal S; Agarwal N
    Int J Gynaecol Obstet; 2007 Jun; 97(3):190-4. PubMed ID: 17382331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five years' experience with a small intracervical/intrauterine levonorgestrel-releasing device.
    Pakarinen P; Luukkainen T
    Contraception; 2005 Nov; 72(5):342-5. PubMed ID: 16246659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.